Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

PURPOSE: The origin licensing factors minichromosome maintenance 2 (Mcm2) and Geminin have recently been identified as critical regulators of growth and differentiation. Here we have investigated the regulation of these licensing factors together with Ki67 to further elucidate the cell cycle kineti...

書目詳細資料
Main Authors:	Dudderidge, T, Stoeber, K, Loddo, M, Atkinson, G, Fanshawe, T, Griffiths, D, Williams, G
格式:	Journal article
語言:	English
出版:	2005

相似書籍

Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
由: Kingsbury, SR, et al.
出版: (2005)

Ki-67 and MCM-2 in Dental Follicle and Odontogenic Cysts: The Effects of Inflammation on Proliferative Markers
由: Nurhan Güler, et al.
出版: (2012-01-01)

Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
由: Marzena Podhorska-Okolow, et al.
出版: (2010-11-01)

MCM3 proliferative index is worthier over Ki-67 in the characterization of salivary gland tumors
由: Ritika Raja, et al.
出版: (2021-01-01)

MCM3 and Ki67 proliferation markers in odontogenic cysts and ameloblastoma
由: Zohreh Jaafari-Ashkavandi, et al.
出版: (2019-01-01)

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
由: Arisa Nishimukai, et al.
出版: (2017-01-01)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
由: I. Pergolini, et al.
出版: (2019-10-01)

Gene experison of cell proliferative marker Ki67 in breast cancer
由: Golmohammadi R (PhD), et al.
出版: (2011-09-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
由: Christina Marouda, et al.
出版: (2024-01-01)

Evaluation of Nuclear Morphometry and Ki-67 Proliferative Marker in Astrocytomas: An Ambispective Study
由: Palak Nanda, et al.
出版: (2023-01-01)

A study on the role of proliferative index marker Ki67 in breast carcinoma
由: Vijetha Vikram, et al.
出版: (2022-11-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
由: Nasrin Shayanfar, et al.
出版: (2010-06-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
由: Nasrin Shayanfar, et al.
出版: (2010-05-01)

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
由: Huberman Joel, et al.
出版: (2006-08-01)

MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
由: Muhammad Zain Mehdi, et al.

Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67
由: Ramesh Babu Telugu, et al.
出版: (2016-01-01)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
由: Gasperetti F, et al.
出版: (2011-03-01)

Expression of proliferative marker Ki-67 in epithelial dysplasia and squamous cell carcinoma of oral cavity
由: Payal Doctor, et al.
出版: (2023-04-01)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
由: Bachmann Ingeborg M, et al.
出版: (2010-04-01)

Comment on “PCNA and Ki67: Prognostic proliferation markers for oral cancer”
由: Muthupandian Saravanan
出版: (2024-06-01)

Expression of Ki67 as a Prognostic Marker in Invasive Breast Carcinoma
由: Rashi Ahuja, et al.
出版: (2017-07-01)

Association of degree of expression of ki 67 proliferative cell marker with aggressive giant cell tumor of the bone
由: Wan Faisham Nu Man, Wan Ismail
出版: (2013)

Geminin is required for the maintenance of pluripotency.
由: Golnaz A Tabrizi, et al.
出版: (2013-01-01)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
由: Dorsay Sadeghian, et al.
出版: (2022-02-01)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
由: Fahimeh Rezazadeh, et al.
出版: (2017-09-01)

KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME
由: G.S. Starodub, et al.
出版: (2016-04-01)

The expression of Ki-67 marker in the hydatidiform mole
由: Ecaterina Carpenco, et al.
出版: (2022-12-01)

Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
由: Fatima S. Al-Sarraf, et al.
出版: (2015-07-01)

The importance of prognostic markers of tumor progression Ki-67 and р53 in the breast cancer
由: Bondareva V.A., et al.
出版: (2007-01-01)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients.
由: Yunbao Pan, et al.
出版: (2017-01-01)

Clinicopathologic study and Ki-67 proliferative marker evaluation in human osteosarcomas Estudo clinicopatológico com avaliação do índice de proliferação celular avaliado pelo Ki-67 em osteossarcomas humanos
由: Larissa Cardoso Marinho, et al.
出版: (2005-12-01)

Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
由: Dudderidge, T, et al.
出版: (2007)

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx
由: Agnieszka Pinkowska, et al.
出版: (2021-12-01)

Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma
由: Ela Araz Server, et al.
出版: (2019-04-01)

Proliferative activity of myeloma cells determined by Ki-67 antibody: Biological and clinical significance
由: Marković Olivera, et al.
出版: (2005-01-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
由: T. A. Bogush, et al.
出版: (2023-07-01)

Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas
由: Mojca Založnik, et al.
出版: (2024-07-01)

Role of Proliferative Marker (Ki-67) and ER, PR in Cervical Epithelial Lesions with Clinicopathological Association: A Cross-sectional Study
由: Shrabani Mitra, et al.
出版: (2025-02-01)

MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma
由: Sarocha Vivatvakin, et al.
出版: (2021-07-01)

Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma
由: Betül Bolat Küçükzeybek, et al.
出版: (2013-09-01)